Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening

Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening

Recent development of immune checkpoint inhibitors has revolutionized cancer immunotherapy. Although these drugs show dramatic effects on a subset of cancer patients, many other tumors are non-responsive and the pathological mechanism of the resistance is largely unknown. To identify genes underlyin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dan Zhao, Ravindra Deshpande, Kerui Wu, Abhishek Tyagi, Sambad Sharma, Shih-Ying Wu, Fei Xing, Stacey O'Neill, Jimmy Ruiz, Feng Lyu, Kounosuke Watabe
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Neoplasia: An International Journal for Oncology Research
Subjects:	In vivo CRISPR screening TUBB3 Anti-PD-1 PDL-1 Lung cancer immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558624001416
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology
by: Athanasia Stoupa, et al.
Published: (2018-11-01)

MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy
by: Ravindra Pramod Deshpande, et al.
Published: (2025-03-01)

Programmed death ligand I (PDL-1) Expression in renal cell carcinoma: A retrospective cohort study
by: Zainab Mohammed Ali, et al.
Published: (2024-06-01)

Transcription factor NFKB1 mediates TUBB6 to promote the proliferation and suppress apoptosis in glioma via Wnt/β-catenin signaling pathway
by: Yan Li, et al.
Published: (2025-04-01)

TUBB2B regulates epithelial-mesenchymal transition via interaction with Vimentin to promote glioma migration and invasion
by: Junxi Li, et al.
Published: (2024-12-01)

A triple-targeting “nano-brake” remodeling the impaired immune microenvironment in skin lesions for psoriasis treatment
by: Ruijie Chen, et al.
Published: (2025-06-01)

Targeting TUBB2B inhibits triple-negative breast cancer growth and brain-metastatic colonization
by: Qingling He, et al.
Published: (2025-02-01)

Role of FHOD1 in tumor cells and tumor immune microenvironment
by: Yang Yang, et al.
Published: (2025-04-01)

NRAS tumor mutations are associated with reduced odds of dermatologic adverse events in patients with metastatic melanoma receiving immune checkpoint inhibitors
by: Michael S. Chang, MD, et al.
Published: (2025-02-01)

Corrigendum to “Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy” [Bioact. Mater. 34 (2024) 466–481]
by: Peishan Li, et al.
Published: (2025-10-01)

Pathogenic variants of TUBB8 cause oocyte spindle defects by disrupting with EB1/CAKP5 interactions and potential treatment targeting microtubule acetylation through HDAC6 inhibition
by: Hui Luo, et al.
Published: (2025-01-01)

RETRACTED ARTICLE: Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions
by: Shih-Ying Wu, et al.
Published: (2021-03-01)

Retraction Note: Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions
by: Shih-Ying Wu, et al.
Published: (2025-05-01)

CRISPR/Cas9 Reduces Viral Load in a BALB/c Mouse Model of Ocular Herpes Infection
by: Luiza Silveira Garcia, et al.
Published: (2025-07-01)

A Novel Variant in TUBB4B Causes Progressive Cone‐Rod Dystrophy and Early Onset Sensorineural Hearing Loss
by: Margherita Scarpato, et al.
Published: (2025-02-01)

Immune-related adverse events following checkpoint inhibitor treatment in head and neck cancers: A comprehensive review
by: Remi Kessler, et al.
Published: (2023-06-01)

Immune Checkpoint Inhibitors in Melanoma Treatment: Advances and Obstacles
by: A. V. Sultanbaev
Published: (2025-04-01)

Emerging immune checkpoint inhibitors for the treatment of oropharyngeal squamous cell carcinoma
by: Pandiselvi Ravi, et al.
Published: (2024-12-01)

Clinicopathological correlation and expression of PD-L1 in cervical carcinoma: An immunohistochemical study
by: Arshdeep Kaur, et al.
Published: (2024-12-01)

CRISPR/Cas9-mediated PD-1 attenuation enhances tumor infiltrating lymphocyte-based adoptive cellular therapy in humanized-PDX model of hepatocellular carcinoma
by: Wu Ge, et al.
Published: (2025-10-01)

Extra-Nodal Follicular Dendritic Cell Sarcoma with Unusual Morphological Features and PDL1 Expression
by: Manali Ranade, et al.

Programmed Death Ligand 1 expression in Urothelial Carcinoma.A retrospective study in Duhok City-Iraq.
by: Zuzan Shawkat Mustafa, et al.
Published: (2024-06-01)

Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer
by: Yang Li, et al.
Published: (2025-04-01)

Investigation the role of SIRT3, SIRT7, NFATC1, and PDL-1 genes in androgenetic alopecia
by: Hadis Abbasian, et al.
Published: (2024-11-01)

Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer
by: Bridget E. Crossman, et al.
Published: (2025-05-01)

Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy
by: Kuirong Mao, et al.
Published: (2025-01-01)

Production of novel theranostic nano-vector based on superparamagnetic iron oxide nanoparticles/miR-497 targeting colorectal cancer
by: Asmaa M. Elfiky, et al.
Published: (2025-02-01)

Comparison of CRISPR-Cas9, CRISPR-Cas12f1, and CRISPR-Cas3 in eradicating resistance genes KPC-2 and IMP-4
by: Jun Huang, et al.
Published: (2025-06-01)

RETRACTED ARTICLE: Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung
by: Abhishek Tyagi, et al.
Published: (2021-01-01)

Retraction Note: Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung
by: Abhishek Tyagi, et al.
Published: (2025-05-01)

Immunotherapy in nonsmall cell lung cancer (basket of choices)
by: Abhishek Raj
Published: (2020-01-01)

Application of CRISPR/Cas9 technology in the modeling of Gaucher disorder
by: Mehran Reyhani-Ardabili, et al.
Published: (2024-12-01)

CRISPR/Cas-Based Ex Vivo Gene Therapy and Lysosomal Storage Disorders: A Perspective Beyond Cas9
by: Andrés Felipe Leal, et al.
Published: (2025-07-01)

Silk Fibroin Nanoparticles for Enhanced Cuproptosis and Immunotherapy in Pancreatic Cancer Treatment
by: Si Gao, et al.
Published: (2025-05-01)

Identification of therapeutic targets for chronic kidney disease through Mendelian randomization analysis of druggable genes
by: Run-Sen Liang, et al.
Published: (2025-03-01)

Comprehensive approaches to design efficient gRNA for SDN1-CRISPR/Cas9 genome editing in wheat
by: Tushadri Singh, et al.
Published: (2025-07-01)

Microtubule Protein β<sub>III</sub>-Tubulin: Structure, Expression and Functions in Normal and Tumor Cells
by: I. A. Mamichev, et al.
Published: (2020-05-01)

Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
by: Lorenza Bridi Todeschini, et al.
Published: (2025-01-01)

Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI
by: Abhishek Tyagi, et al.
Published: (2025-07-01)

Adeno-associated virus-clustered regularly interspaced short palindromic repeats/cas9‑mediated ovarian cancer treatment targeting PD-L1
by: Tamaki Yahata, et al.
Published: (2025-04-01)